301 - 350 of 8808 Results
Title
Year
-
RESTRICTEDTitle: Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson’s disease? A critical reappraisalJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1767Issue #:Start Page: 147434End Page: 147434Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brainres.2021.147434Best OA location URL: https://doi.org/10.1016/j.brainres.2021.147434Citation Count: 33
-
RESTRICTEDTitle: Immunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson’s DiseaseJournal Name: Brain SciencesPublisher: MDPI AGVol: 6Issue #: 4Start Page: 41End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci6040041Best OA location URL: https://www.mdpi.com/2076-3425/6/4/41/pdf?version=1474633139Citation Count: 18
-
RESTRICTEDTitle: Adaptive preconditioning in neurological diseases – therapeutic insights from proteostatic perturbationsJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1648Issue #:Start Page: 603End Page: 616Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2016.02.033Best OA location URL: https://doi.org/10.1016/j.brainres.2016.02.033Citation Count: 39
-
RESTRICTEDTitle: Local institutional review board (IRB) review of a multicenter trial: Local costs without local contextJournal Name: Annals of NeurologyPublisher: WileyVol: 67Issue #: 2Start Page: 258End Page: 260Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.21831Best OA location URL: https://europepmc.org/articles/pmc2848288?pdf=renderCitation Count: 45
-
RESTRICTEDTitle: Effect Modification between Genes and Environment and Parkinson's Disease RiskJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 715End Page: 724Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.26467Best OA location URL: https://doi.org/10.1002/ana.26467Citation Count: 15
-
RESTRICTEDTitle: Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkersJournal Name: Brain Imaging and BehaviorPublisher: Springer Science and Business Media LLCVol: 8Issue #: 2Start Page: 183End Page: 207Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s11682-013-9262-zBest OA location URL: https://link.springer.com/content/pdf/10.1007/s11682-013-9262-z.pdfCitation Count: 148
-
RESTRICTEDTitle: Neural Subtype Specification from Embryonic Stem CellsJournal Name: Brain PathologyPublisher: WileyVol: 16Issue #: 2Start Page: 132End Page: 142Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1750-3639.2006.00008.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095876Citation Count: 143
-
RESTRICTEDTitle: Kv1.3 K+Channel Physiology Assessed by Genetic and Pharmacological ModulationJournal Name: PhysiologyPublisher: American Physiological SocietyVol: 38Issue #: 1Start Page: 25End Page: 41Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1152/physiol.00010.2022Citation Count: 9
-
RESTRICTEDTitle: Genome-wide contribution of common short-tandem repeats to Parkinson’s disease genetic riskJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 1Start Page: 65End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/brain/awac301Best OA location URL: https://academic.oup.com/brain/article-pdf/146/1/65/49693430/awac301.pdfCitation Count: 15
-
RESTRICTEDTitle: Safety of deep brain stimulation in pregnancy: A comprehensive reviewJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2022.997552Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2022.997552/pdfCitation Count: 3
-
RESTRICTEDTitle: Use of AbobotulinumtoxinA in Adults with Cervical Dystonia: A Systematic Literature ReviewJournal Name: ToxinsPublisher: MDPI AGVol: 12Issue #: 8Start Page: 470End Page: 470Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/toxins12080470Best OA location URL: https://www.mdpi.com/2072-6651/12/8/470/pdf?version=1595909472Citation Count: 9
-
RESTRICTEDTitle: Comparison of the Efficacy of Deep Brain Stimulation in Different Targets in Improving Gait in Parkinson's Disease: A Systematic Review and Bayesian Network Meta-AnalysisJournal Name: Frontiers in Human NeurosciencePublisher: Frontiers Media SAVol: 15Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnhum.2021.749722Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnhum.2021.749722/pdfCitation Count: 4
-
RESTRICTEDTitle: The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily LivingJournal Name: Journal of Visualized ExperimentsPublisher: MyJove CorporationVol:Issue #: 185Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3791/63978Best OA location URL: https://www.jove.com/pdf/63978/the-immersive-cleveland-clinic-virtual-reality-shopping-platform-forCitation Count: 4
-
RESTRICTEDTitle: Small Molecule Metabolites at the Host–Microbiota InterfaceJournal Name: The Journal of ImmunologyPublisher: The American Association of ImmunologistsVol: 207Issue #: 7Start Page: 1725End Page: 1733Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.4049/jimmunol.2100528Best OA location URL: https://www.jimmunol.org/content/jimmunol/207/7/1725.full.pdfCitation Count: 16
-
RESTRICTEDTitle: Depression and Parkinson's disease: a Chicken-Egg storyJournal Name: AIMS NeurosciencePublisher: American Institute of Mathematical Sciences (AIMS)Vol: 9Issue #: 4Start Page: 479End Page: 490Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3934/neuroscience.2022027Best OA location URL: https://doi.org/10.3934/neuroscience.2022027Citation Count: 2
-
RESTRICTEDTitle: Diagnosis and Treatment of Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 323Issue #: 6Start Page: 548End Page: 548Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2019.22360Citation Count: 1523
-
RESTRICTEDTitle: Promising drug targets and associated therapeutic interventions in Parkinson’s diseaseJournal Name: Neural Regeneration ResearchPublisher: MedknowVol: 16Issue #: 9Start Page: 1730End Page: 1730Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/1673-5374.306066Best OA location URL: https://doi.org/10.4103/1673-5374.306066Citation Count: 75
- An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration2022RESTRICTEDTitle: An atypical ubiquitin ligase at the heart of neural development and programmed axon degenerationJournal Name: Neural Regeneration ResearchPublisher: MedknowVol: 17Issue #: 11Start Page: 2347End Page: 2347Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.4103/1673-5374.338992Best OA location URL: https://doi.org/10.4103/1673-5374.338992Citation Count: 8
- Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical Trials2021RESTRICTEDTitle: Gene Therapy in Movement Disorders: A Systematic Review of Ongoing and Completed Clinical TrialsJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.648532Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.648532/pdfCitation Count: 21
-
RESTRICTEDTitle: Microglia modulate neurodegeneration in Alzheimer’s and Parkinson’s diseasesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 370Issue #: 6512Start Page: 66End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abb8587Best OA location URL: https://discovery.ucl.ac.uk/10113826/1/Hong_abb8587%20copy.pdfCitation Count: 229
-
RESTRICTEDTitle: Molecular Tweezers: Supramolecular Hosts with Broad-Spectrum Biological ApplicationsJournal Name: Pharmacological ReviewsPublisher: American Society for Pharmacology & Experimental Therapeutics (ASPET)Vol: 75Issue #: 2Start Page: 263End Page: 308Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1124/pharmrev.122.000654Citation Count: 3
-
RESTRICTEDTitle: Management of psychiatric and cognitive complications in Parkinson’s diseaseJournal Name: BMJPublisher: BMJVol:Issue #:Start Page: e068718End Page: e068718Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/bmj-2021-068718Best OA location URL: https://www.bmj.com/content/bmj/379/bmj-2021-068718.full.pdfCitation Count: 18
-
RESTRICTEDTitle: Inflammatory bowel disease and Parkinson’s disease: common pathophysiological linksJournal Name: GutPublisher: BMJVol:Issue #:Start Page: gutjnlEnd Page: 322429Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/gutjnl-2020-322429Best OA location URL: https://lirias.kuleuven.be/bitstream/123456789/663875/2/gutjnl-2020-322429_main_18_Aug_clean.pdfCitation Count: 93
-
RESTRICTEDTitle: Fidelity of the PINK1 knockout rat to oxidative stress and other characteristics of Parkinson diseaseJournal Name: Free Radical Biology and MedicinePublisher: Elsevier BVVol: 163Issue #:Start Page: 88End Page: 101Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.freeradbiomed.2020.12.004Citation Count: 11
-
RESTRICTEDTitle: The role of immune-mediated alterations and disorders in ALS diseaseJournal Name: Human ImmunologyPublisher: Elsevier BVVol: 82Issue #: 3Start Page: 155End Page: 161Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.humimm.2021.01.017Best OA location URL: https://doi.org/10.1016/j.humimm.2021.01.017Citation Count: 19
-
RESTRICTEDTitle: Nano drug delivery systems for antisense oligonucleotides (ASO) therapeuticsJournal Name: Journal of Controlled ReleasePublisher: Elsevier BVVol: 352Issue #:Start Page: 861End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jconrel.2022.10.050Citation Count: 34
-
RESTRICTEDTitle: Autophagy in hepatic adaptation to stressJournal Name: Journal of HepatologyPublisher: Elsevier BVVol: 72Issue #: 1Start Page: 183End Page: 196Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.jhep.2019.08.026Best OA location URL: http://manuscript.elsevier.com/S0168827819305203/pdf/S0168827819305203.pdfCitation Count: 124
-
RESTRICTEDTitle: From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and OpportunitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167932End Page: 167932Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2022.167932Best OA location URL: https://doi.org/10.1016/j.jmb.2022.167932Citation Count: 9
-
RESTRICTEDTitle: Novel fluid biomarkers to differentiate frontotemporal dementia and dementia with Lewy bodies from Alzheimer's disease: A systematic reviewJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 415Issue #:Start Page: 116886End Page: 116886Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.116886Best OA location URL: https://discovery.ucl.ac.uk/10102806/1/Rizig_Revised%20MS%20-%20Clean%20Version.pdfCitation Count: 16
-
RESTRICTEDTitle: Functional neurological disorder and somatic symptom disorder in Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120017End Page: 120017Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120017Citation Count: 12
-
RESTRICTEDTitle: Parkinsonism and tremor syndromesJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 433Issue #:Start Page: 120018End Page: 120018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120018Best OA location URL: http://www.jns-journal.com/article/S0022510X21027143/pdfCitation Count: 12
-
RESTRICTEDTitle: Improving functional disability in patients with tremor: A clinical perspective of the efficacies, considerations, and challenges of assistive technologyJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 435Issue #:Start Page: 120197End Page: 120197Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2022.120197Best OA location URL: http://www.jns-journal.com/article/S0022510X22000594/pdfCitation Count: 13
- How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review2021RESTRICTEDTitle: How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative reviewJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00160-3Best OA location URL: https://www.nature.com/articles/s41531-021-00160-3.pdfCitation Count: 59
-
RESTRICTEDTitle: LRRK2 signaling in neurodegeneration: two decades of progressJournal Name: Essays in BiochemistryPublisher: Portland Press Ltd.Vol: 65Issue #: 7Start Page: 859End Page: 872Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/ebc20210013Citation Count: 10
- Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyond2021RESTRICTEDTitle: Modelling the functional genomics of Parkinson’s disease inCaenorhabditis elegans:LRRK2and beyondJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 41Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20203672Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/41/9/BSR20203672/920054/bsr-2020-3672c.pdfCitation Count: 9
- Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal Dementia2020RESTRICTEDTitle: Chronic Traumatic Encephalopathy: A Comparison with Alzheimer's Disease and Frontotemporal DementiaJournal Name: Seminars in NeurologyPublisher: Georg Thieme Verlag KGVol: 40Issue #: 04Start Page: 394End Page: 410Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0040-1715134Citation Count: 8
-
RESTRICTEDTitle: Allosteric inhibition of LRRK2, where are we nowJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 48Issue #: 5Start Page: 2185End Page: 2194Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1042/bst20200424Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/48/5/2185/896516/bst-2020-0424c.pdfCitation Count: 10
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: On demand therapy for Parkinson’s disease patients: Opportunities and choicesJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 7Start Page: 721End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2021.1936087Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1936087?needAccess=trueCitation Count: 16
- Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titration2021RESTRICTEDTitle: Pregabalin for neuropathic pain in primary care settings: recommendations for dosing and titrationJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2020.1857992Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2020.1857992?needAccess=trueCitation Count: 10
-
RESTRICTEDTitle: A systematic review of group intervention for acquired dysarthria in adultsJournal Name: Disability and RehabilitationPublisher: Informa UK LimitedVol: 44Issue #: 13Start Page: 3002End Page: 3018Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/09638288.2020.1859629Citation Count: 9
-
RESTRICTEDTitle: Targeting mitophagy in Parkinson's diseaseJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 296Issue #:Start Page: 100209End Page: 100209Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1074/jbc.rev120.014294Best OA location URL: https://doi.org/10.1074/jbc.rev120.014294Citation Count: 72
-
RESTRICTEDTitle: Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an updateJournal Name: Expert Opinion on Emerging DrugsPublisher: Informa UK LimitedVol: 25Issue #: 2Start Page: 131End Page: 144Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728214.2020.1763954Citation Count: 13
-
RESTRICTEDTitle: Identifying and responding to fatigue and apathy in Parkinson’s disease: a review of current practiceJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 5Start Page: 477End Page: 495Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1752669Citation Count: 29
-
RESTRICTEDTitle: Therapeutic innovation in Parkinson’s disease: a 2020 update on disease-modifying approachesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 20Issue #: 10Start Page: 1047End Page: 1064Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1800454Citation Count: 12
-
RESTRICTEDTitle: The necroptosis pathway and its role in age-related neurodegenerative diseases: will it open up new therapeutic avenues in the next decade?Journal Name: Expert Opinion on Therapeutic TargetsPublisher: Informa UK LimitedVol: 24Issue #: 7Start Page: 679End Page: 693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14728222.2020.1758668Citation Count: 14
-
RESTRICTEDTitle: A critical review of apomorphine hydrochloride sublingual film for the treatment of Parkinson’s disease ‘OFF’ episodesJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 2Start Page: 169End Page: 177Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/14737175.2020.1855145Citation Count: 9
- Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone2021RESTRICTEDTitle: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicaponeJournal Name: Expert Review of NeurotherapeuticsPublisher: Informa UK LimitedVol: 21Issue #: 9Start Page: 1019End Page: 1033Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14737175.2021.1968298Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/14737175.2021.1968298?needAccess=trueCitation Count: 20
- Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospects2021RESTRICTEDTitle: Noninvasive vagus nerve stimulation in Parkinson’s disease: current status and future prospectsJournal Name: Expert Review of Medical DevicesPublisher: Informa UK LimitedVol: 18Issue #: 10Start Page: 971End Page: 984Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1080/17434440.2021.1969913Best OA location URL: https://doi.org/10.1080/17434440.2021.1969913Citation Count: 17
-
RESTRICTEDTitle: Hallucinations and delusions associated with Parkinson’s disease psychosis: safety of current treatments and future directionsJournal Name: Expert Opinion on Drug SafetyPublisher: Informa UK LimitedVol: 21Issue #: 7Start Page: 873End Page: 879Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/14740338.2022.2069240Best OA location URL: https://doi.org/10.1080/14740338.2022.2069240Citation Count: 8